Michael A Mussallem Edwards Lifesciences Corp (EW) insider trading activity

Michael A Mussallem is Director of Edwards Lifesciences Corp. Currently has a direct ownership of 4,485 shares of EW, which is worth approximately $293,677. The most recent transaction as insider was on May 12, 2023, when has been sold 4,485 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.49K

0% 3M change

0% 12M change

Total Value Held $293,677

MICHAEL A MUSSALLEM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 12 2023	BUY Grant, award, or other acquisition	-	4,485 Added 4.95%	86,209 Common Stock
May 10 2023	SELL Bona fide gift	-	9,500 Reduced 9.04%	95,615 Common Stock
May 10 2023	SELL Open market or private sale	$1,761,322 $88.62 p/Share	19,875 Reduced 19.56%	81,724 Common Stock
May 10 2023	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 20.91%	111,099 Common Stock
May 07 2023	BUY Exercise of conversion of derivative security	-	20,777 Added 20.27%	81,724 Common Stock
Apr 14 2023	SELL Bona fide gift	-	9,500 Reduced 10.98%	77,006 Common Stock
Apr 14 2023	SELL Open market or private sale	$1,676,655 $84.36 p/Share	19,875 Reduced 24.59%	60,947 Common Stock
Apr 14 2023	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 24.54%	90,322 Common Stock
Mar 14 2023	SELL Bona fide gift	-	9,500 Reduced 11.71%	71,647 Common Stock
Mar 14 2023	SELL Open market or private sale	$1,542,101 $77.59 p/Share	19,875 Reduced 24.59%	60,947 Common Stock
Mar 14 2023	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 24.54%	90,322 Common Stock
Feb 15 2023	SELL Bona fide gift	-	96,405 Reduced 61.27%	60,947 Common Stock
Feb 14 2023	SELL Bona fide gift	-	9,500 Reduced 5.19%	173,627 Common Stock
Feb 14 2023	SELL Open market or private sale	$1,536,138 $77.29 p/Share	19,875 Reduced 11.21%	157,352 Common Stock
Feb 14 2023	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
Jan 13 2023	SELL Open market or private sale	$1,552,038 $78.09 p/Share	19,875 Reduced 11.21%	157,352 Common Stock
Jan 13 2023	SELL Bona fide gift	-	9,500 Reduced 5.09%	177,227 Common Stock
Jan 13 2023	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
Dec 14 2022	SELL Bona fide gift	-	9,500 Reduced 5.31%	169,507 Common Stock
Dec 14 2022	SELL Open market or private sale	$1,526,996 $76.83 p/Share	19,875 Reduced 11.21%	157,352 Common Stock
Dec 14 2022	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
Nov 14 2022	SELL Open market or private sale	$1,485,855 $74.76 p/Share	19,875 Reduced 11.21%	157,352 Common Stock
Nov 14 2022	SELL Bona fide gift	-	9,500 Reduced 5.21%	172,927 Common Stock
Nov 14 2022	BUY Exercise of conversion of derivative security	$1,034,000 $35.2 p/Share	29,375 Added 13.59%	186,727 Common Stock
Oct 14 2022	SELL Bona fide gift	-	9,500 Reduced 5.24%	171,849 Common Stock

MAM

Michael A Mussallem

Director

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account